Title
Category
Credits
Event date
Cost
Advancements and Implications of CAR T-Cell Therapy in the Treatment of Hematologic Malignancies
  • Disease management
  • Oncology
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore advancements in chimeric antigen receptor (CAR) T-cell therapies in treating hematologic malignancies, particularly those of B-cell origin, with a focus on their efficacy and long-term outcomes.